Measures to minimise risk of liver injury with Veoza
Platform can now be used to report shortages of centrally authorised medicines
Addressing AMR in a One Health approach
Leqembi’s benefits outweigh risks in a restricted patient population
A new tool to respond rapidly to emerging animal and public health threats
Find medicine
What's new
FAQs
Latest news
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting.
Doxycycline: currently available evidence not supporting link with risk of suicidality
Marketing authorisation holders can now use the platform to report shortages of centrally authorised human medicines.
Use of opioid medicines with Mysimba may lead to serious side effects
Leqembi (lecanemab) recommended for treatment of early Alzheimer’s disease
Re-examination concludes that benefits outweigh risks in a restricted patient population
Information for you
Patients and carers
Healthcare professionals
Animal health professionals
Pharmaceutical Industry
Media
